Evidence for a genetic basis for altitude-related illness

High Altitude Medicine and Biology

Volumn 7, Issue 2, 2006, Pages 150-167

  Rupert, Jim L ^a   Koehle, Michael S ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Altitude sickness; AMS; CMS; Genetic epidemiology; HACE; HAPE; Mountain sickness

Indexed keywords

ALTITUDE; ALTITUDE ACCLIMATIZATION; ALTITUDE DISEASE; BRAIN DISEASE; BRAIN EDEMA; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE RESISTANCE; EPIDEMIOLOGICAL DATA; EVIDENCE BASED MEDICINE; FAMILY STUDY; FATALITY; GENE CLUSTER; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEMATOLOGIC DISEASE; HUMAN; LUNG DISEASE; LUNG EDEMA; MEDICAL RESEARCH; OXYGEN SUPPLY; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW;

ACUTE DISEASE; ALTITUDE SICKNESS; BRAIN EDEMA; EVIDENCE-BASED MEDICINE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION, PULMONARY; INDIANS, NORTH AMERICAN; PULMONARY EDEMA; TRAVEL;

EID: 33745902783     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/ham.2006.7.150     Document Type: Review

References (100)

1. Ahsan A., Charu R., Pasha M.A., Norboo T., Charu R., Afrin F., Ahsan A., and Baig M.A. (2004). eNOS allelic variants at the same locus associate with HAPE and adaptation. Thorax 59:1000-1002.
2. Altshuler D., Brooks L.D., Chakravarti A., Collins F.S., Daly M.J., and Donnelly P. (2005). A haplotype map of the human genome. Nature. 437:1299-1320.
3. Bartsch P., Maggiorini M., Ritter M., Noti C., Vock P., and Oelz O. (1991). Prevention of high-altitude pulmonary edema by nifedipine. N. Engl. J. Med. 325:1284-1289.
4. Bartsch P., Bailey D.M., Berger M.M., Knauth M., and Baumgartner R.W. (2004). Acute mountain sickness: controversies and advances. High Alt. Med. Biol. 5:110-124.
5. Bartsch P., Grunig E., Hohenhaus E., and Dehnert C. (2001). Assessment of high altitude tolerance in healthy individuals. High Alt. Med. Biol. 2:287-296.
6. Basnyat B., and Murdoch D.R. (2003). High-altitude-related illness. Lancet. 361:1967-1974.
7. Basnyat B., Subedi D., Sleggs J., Lemaster J., Bhasyal G., Aryal B., and Subedi N. (2000). Disoriented and ataxic pilgrims: an epidemiological study of acute mountain sickness and high-altitude cerebral edema at a sacred lake at 4300 m in the Nepal Himalayas. Wilderness Environ. Med. 11:89-93.
8. Beall C.M. (2000). Tibetan and Andean patterns of adaptation to high-altitude hypoxia. Hum. Biol. 72(1): 201-228.
9. Boehringer S., Epplen J.T., and Krawczak M. (2000). Genetic association studies of bronchial asthma-a need for Bonferroni correction? Hum. Genet. 107:197.
10. Boomsma D., Busjahn A., and Peltonen L. (2002). Classical twin studies and beyond. Natl. Rev. Genet. 3:872-882.
11. Brutsaert T.D. (2001). Genetic and environmental adaptation in high altitude natives. Conceptual, methodological, and statistical concerns. Adv. Exp. Med. Biol. 502:133-151.
12. Brutsaert T.D., Parra E.J., Shriver M.D., Gamboa A., Rivera-Ch. M., and Leon-Velarde F. (2005). Ancestry explains the blunted ventilatory response to sustained hypoxia and lower exercise ventilation of Quechua altitude natives. Am. J. Physiol. 289:R225-R234.
13. Busch T., Bartsch P., Pappert D., Grunig E., Hildebrandt W., Elser H., Falke K.J., and Swenson E.R. (2001). Hypoxia decreases exhaled nitric oxide in mountaineers susceptible to high-altitude pulmonary edema. Am. J. Respir. Crit. Care Med. 163:368-373.
14. Channon K.M., and Guzik T.J. (2002). Mechanisms of superoxide production in human blood vessels: relationship to endothelial dysfunction, clinical and genetic risk factors. J. Physiol. Pharmacol. 53:515-524.
15. Collins D.D., Scoggin C.H., Zwillich C.W., and Weil J.V. (1978). Hereditary aspects of decreased hypoxic response. J. Clin. Invest. 62:105-110.
16. Decoq P., and Vinckier F. (1995). [Down syndrome: 1. Medical aspects]. Rev. Belge Med. Dent. 50:43-52 [Fr].
17. Dehnert C., Weymann J., Montgomery H.E., Woods D., Maggiorini M., Scherrer U., Gibbs J.S., and Bartsch P. (2002). No association between high-altitude tolerance and the ACE I/D gene polymorphism. Med. Sci. Sports. Exerc. 34:1928-1933.
18. Droma Y., Hanaoka M., Hotta J., Katsuyama Y., Ota M., Kobayashi T., and Kubo K. (2003). The r506 Q mutation of coagulation factor V gene in high altitude pulmonary-edema-susceptible subjects. High. Alt. Med. Biol. 4:497-498.
19. Droma Y., Hanaoka M., Ota M., Katsuyama Y., Koizumi T., Fujimoto K., Kobayashi T., and Kubo K. (2002). Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema. Circulation. 106:826-830.
20. Durmowicz A.G. (2001). Pulmonary edema in 6 children with Down syndrome during travel to moderate altitudes. Pediatrics. 108:443-447.
21. Fedorova L., and Fedorov A. (2003). Introns in gene evolution. Genetica. 118:123-131.
22. Forster P. (1984). Reproducibility of individual response to exposure to high altitude. Br. Med. J. (Clin. Res. Ed.) 289:1269.
23. Fred H., Schmidt A., Bates T., and Hecht H. (1962). Acute pulmonary edema of altitude. Circulation. 25:929-937.
24. Freel M., McKenzie S., Friel E., Ingram M., Davies E., Fraser R., Dominiczak A., Caulfield M., and Connell J. (2004). Effect of variation at the aldosterone synthase locus (CYP11B2) on adrenal 11-beta hydroxylation: pilot data from the MRC BRIGHT Study. Endocr. Abstracts 8 OC22.
25. Gaillard S., Dellasanta P., Loutan L., and Kayser B. (2004). Awareness, prevalence, medication use, and risk factors of acute mountain sickness in tourists trekking around the Annapurnas in Nepal: a 12-year follow-up. High Alt. Med. Biol. 5:410-419.
26. Gallagher S.A., and Hackett P.H. (2004). High-altitude-related illness. Emerg. Med. Clin. North Am. 22:329-355, viii.
27. Garruto R.M., Chin C.T., Weitz C.A., Liu J.C., Liu R.L., and He, X. (2003). Hematological differences during growth among Tibetans and Han Chinese born and raised at high altitude in Qinghai, China. Am. J. Phys. Anthropol. 122:171-183.
28. Ge R.-L., and Helun H. (2001). Current concept of chronic mountain sickness: pulmonary hypertension-related high-altitude heart disease. Wilderness Environ. Med. 12:190-194.
29. Gupta M., Rao K., Anand I., Banerjee A., and Boparai M. (1992). Lack of smooth muscle in the small pulmonary arteries of the native Ladakhi. Is the Himalayan highlander adapted? Am. Rev. Respir. Dis. 145:1201-1214.
30. Hackett P. H., and Roach R. C. (2001). High-altitude-related illness. N. Engl. J. Med. 345:107-114.
31. Hackett P.H., and Roach R.C. (2004). High altitude cerebral edema. High Alt. Med. Biol. 5:136-146.
32. Hanaoka M., Droma Y., Hotta J., Matsuzawa Y., Kobayashi T., Kubo K., and Ota M. (2003). Polymorphisms of the tyrosine hydroxylase gene in subjects susceptible to high-altitude pulmonary edema. Chest. 123:54-58.
33. Hanaoka M., Kubo K., Yamazaki Y., Miyahara T., Matsuzawa Y., Kobayashi T., Sekiguchi M., Ota M., and Watanabe H. (1998). Association of high-altitude pulmonary edema with the major histocompatibility complex. Circulation. 97:1124-1128.
34. Heath D., and Williams D.R. (1995). High Altitude Medicine and Pathology. Oxford University Press.
35. Hingorani A.D. (2003). Endothelial nitric oxide synthase polymcrphisms and hypertension. Curr. Hypertens. Rep. 5:19-25.
36. Hirota K., and Semenza G.L. (2005). Regulation of hypoxia-inducible factor 1 by prolyl and asparaginyl hydroxylases. Biochem. Biophys. Res. Commun. 338: 610-616.
37. Hoffmann I.S., Tavares-Mordwinkin R., Castejon A.M., Alfieri A.B., and Cubeddu L.X. (2005). Endothelial nitric oxide synthase polymorphism, nitric oxide production, salt sensitivity and cardiovascular risk factors in Hispanics. J. Hum. Hypertens. 19:233-240.
38. Honigman B., Theis M.K., Koziol-McLain J., Roach R., Yip R., Houston C., Moore L.G., and Pearce P. (1993). Acute mountain sickness in a general tourist population at moderate altitudes. Ann. Intern. Med. 118:587-592.
39. Hotta J., Hanaoka M., Droma Y., Katsuyama Y., Ota M., and Kobayashi T. (2004). Polymorphisms of renin-angiotensin system genes with high-altitude pulmonary edema in Japanese subjects. Chest. 126:825-830.
40. Hultgren H.N., and Marticorena E.A. (1978). High altitude pulmonary edema. Epidemiologic observations in Peru. Chest. 74:372-376.
41. Hultgren H.N., Spickard W.B., Hellriegel K., and Houston C.S. (1961). High altitude pulmonary edema. Medicine (Baltimore). 40:289-313.
42. Jean D., Leal C., Kriemler S., Meijer H., and Moore L.G. (2005). Medical recommendations for women going to altitude. High Alt. Med. Biol. 6:22-31.
43. Jones R., Pembrey M., Golding J., and Herrick D. (2005). The search for genenotype/phenotype associations and the phenome scan. Paediatr. Perinat. Epidemiol. 19:264-275.
44. Kawakami Y., Yoshikawa T., Shida A., and Asanuma Y. (1982). Genetic aspects of serum immunoglobulins and respiratory chemosensitivity. Respiration 43:101-107.
45. Kim E.K., Park J.D., Shim S.Y., Kim H.S., Kim B.I., Choi J.H., and Kim J.E. (2005). Effect of chronic hypoxia on proliferation, apoptosis, and hsp70 expression in mouse bronchiolar epithelial cells. Physiol. Res. (E-pub).
46. Kim H.S., Lee M.M., Oh B.H., Kim K.I., Han K.H., Park S.K., Sohn D.W., You K.Y., Park Y.B., Choi Y.S., and Lee Y.W. (2000). Synergistic effect of angiotensin-converting enzyme and angiotensinogen gene on cardiac hypertrophy. Int. J. Cardiol. 72:151-161.
47. Klein R.J., Zeiss C., Chew E.Y., Tsai J.Y., Sackler R.S., Haynes C., Henning A.K., SanGiovanni J.P., Mane S.M., Mayne S.T., Bracken M.B., Ferris F.L., Ott J., Barnstable C., and Hoh J. (2005). Complement factor H polymorphism in age-related macular degeneration. Science. 308(5720):362-364.
48. Klocke D.L., Decker W.W., and Stepanek J. (1998). Altitude-related illnesses. Mayo Clin. Proc. 73:988-993.
49. Kobayashi T. (1995). [High-altitude pulmonary edema in Japan]. Nihon Kyobu Shikkan Gakkai Zasshi 33 Suppl:1-6 [Ja].
50. Kryger M., Weil J., and Grover R. (1978). Chronic mountain polycythemia: a disorder of the regulation of breathing during sleep? Chest. 73:303-304.
51. Kumar R., Pasha Q., Khan A.P., and Gupta V. (2004). Renin angiotensin aldosterone system and ACE I/D gene polymorphism in high-altitude pulmonary edema. Aviat. Space Environ. Med. 75:981-983.
52. Lakshminarayan S., and Pierson D.J. (1975). Recurrent high altitude pulmonary edema with blunted chemosensitivity. Am. Rev. Respir. Dis. 111:869-872.
53. Leon-Velarde F., Maggiorini M., Reeves J.T., Aldashev A., Asmus I., Bernardi L., Ge R.L., Hackett P., Kobayashi T., Moore L.G., et al. (2005). Consensus statement on chronic and subacute high altitude diseases. High Alt. Med. Biol. 6:147-157.
54. Leon-Velarde F., Ramos M.A., Hernandez J.A., De Idiaquez D., Munoz L.S., Gaffo A., Cordova S., Durand D., and Monge C. (1997). The role of menopause in the development of chronic mountain sickness. Am. J. Physiol. 272:R90-R94.
55. Li F.Z., Zhou F., Jiang C.Z., Sun S.Y., He M.A., Zhang S.Y., Liao R., Zeng H.S., Wu Y.M., and Wu T.C. (2004). [Relationship between heat stress protein 70 gene polymorphisms and the risk of acute mountain sickness]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 22:413-415 [Zh].
56. Lin Z.P., Yiao Q.Y., Miao C.Y., and Chen D.S. (1984). Family susceptibility to high altitude heart disease. In: High Altitude Disease, W.Y. Zhang YB, Liu X.L., eds. Qinghai Press, Xining, China; pp. 268-287.
57. Maggiorini M., Melot C., Pierre S., Pfeiffer F., Greve I., Sartori C., Lepori M., Hauser M., Scherrer U., and Naeije R. (2001). High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation. 103:2078-2083.
58. Mejia O.M., Prchal J.T., Leon-Velarde F., Hurtado A., and Stockton D.W. (2005). Genetic association analysis of chronic mountain sickness in an Andean high-altitude population. Haematologica 90:13-19.
59. Milledge J.S., and Catley D.M. (1984). Angiotensin converting enzyme response to hypoxia in man: its role in altitude acclimatization. Clin. Sci. (Lond.) 67:453-456.
60. Monge C. (1943). Chronic mountain sickness. Physiol. Rev 23:166-184.
61. Montgomery H.E., Marshall R., Hemingway H., Myerson S., Clarkson P., Dollery C., Hayward M., Holliman D.E., Jubb M., World M., et al. (1997). Human gene for physical performance. Nature. 393:221-222.
62. Moore L.G. (2001). Human genetic adaptation to high altitude. High Alt. Med. Biol. 2:257-279.
63. Morrell N.W., Sarybaev A.S., Alikhan A., Mirrakhimov M.M., and Aldashev A.A. (1999). ACE genotype and risk of high altitude pulmonary hypertension in Kyrghyz highlanders. Lancet. 353:814.
64. Norboo T., Saiyed H.N., Angchuk P.T., Tsering P., Angchuk S.T., Phuntsog S.T., Yahya M., Wood S., Bruce N.G., and Ball K.P. (2004). Mini review of high altitude health problems in Ladakh. Biomed. Pharmacother. 58:220-225.
65. Pasha M.A., Charu R., Ahsan A., and Norboo T. (2005). HAPE susceptibility associates with variants of genes of vascular homeostasis. Human Genome Mapping; Genomic Basis of Common Diseases Poster abstract 310.
66. Pei S.X., Chen X.J., Si Ren B.Z., Liu Y.H., Cheng X.S., Harris E.M., Anand I.S., and Harris P.C. (1989). Chronic mountain sickness in Tibet. Q. J. Med. 71:555-574.
67. Perusse L., Rankinen T., Zuberi A., Chagnon Y.C., Weisnagel S.J., Argyropoulos G., Walts B., Snyder E.E., and Bouchard C. (2005). The human obesity gene map: the 2004 update. Obes. Res. 13:381-490.
68. Reátegui L. (1969). [Soroche crónico: observaciones realizadas en el Cuzco en 30 casos]. Rev. Peru Cardiol. 15, 45-59 [Es].
69. Reeves J.T., and León-Velarde F. (2004). Chronic mountain sickness: recent studies of the relationship between hemoglobin concentration and oxygen transport. High Alt. Med. Biol. 5:147-155.
70. Reich D., and Patterson N. (2005). Will admixture mapping work to find disease genes? Philos. Trans. Royal Soc. Lond. B. Biol. Sci. 360 (1460):1605-1607.
71. Reich D., Patterson N., De Jager P.L., McDonald G.J., Waliszewska A., Tandon A., Lincoln R.R., DeLoa C., Fruhan S.A., Cabre P., Bera O., Semana G., Kelly M.A., Francis D.A., Ardlie K., Khan O., Cree B.A., Hauser S.L., Oksenberg J.R., and Hafler D.A. (2005). A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility. Natl. Genet. 37(10):1113-1118.
72. Ri-Li G., Chase P.J., Witkowski S., Wyrick B.L., Stone J.A., Levine B.D., and Babb T.G. (2003). Obesity: associations with acute mountain sickness. Ann. Intern. Med. 139:253-257.
73. Rupert J.L. (2000). Genetic variation and adaptation in the Quechua, a high altitude native population. Vancouver: PhD thesis, University of British Columbia.
74. Rupert J.L., and Hochachka P.W. (2001). The evidence for hereditary factors contributing to high altitude adaptation in Andean natives: a review. High Alt. Med. Biol. 2(2):235-256.
75. Rupert J.L., Kidd K.K., Norman L.E., Monsalve M.V., Hochachka P.W., and Devine D.V. (2003). Genetic polymorphisms in the renin-angiotensin system in high-altitude and low-altitude Native American populations. Ann. Hum. Genetics 67:17-25.
76. Salisbury B.A., Pungliya M., Choi J.Y., Jiang R., Sun X.J., and Stephens J.C. (2003). SNP and haplotype variation in the human genome. Mutat. Res. 526:53-61.
77. Sartori C., Vollenweider L., Loffler B.M., Delabays A., Nicod P., Bartsch P., and Scherrer U. (1999). Exaggerated endothelin release in high-altitude pulmonary edema. Circulation. 99:2665-2668.
78. Saxena S., Kumar R., Madan T., Gupta V., Muralidhar K., and Sarma P.U. (2005). Association of polymorphisms in pulmonary surfactant protein A1 and A2 genes with high-altitude pulmonary edema. Chest 128:1611-1619.
79. Sayed-Tabatabaei F.A., Schut A.F., Hofman A., Bertoli-Avella A.M., Vergeer J., Witteman J.C., and van Duijn C.M. (2004). A study of gene-environment interaction on the gene for angiotensin converting enzyme: a combined functional and population based approach. J. Med. Genetics 41:99-103.
80. Schneider M., Bernasch D., Weymann J., Holle R., and Bartsch P. (2002). Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate. Med. Sci. Sports Exerc. 34:1886-1891.
81. Schoene R.B. (2004). Unraveling the mechanism of high altitude pulmonary edema. High Alt. Med. Biol. 5:125-135.
82. Schroder O., Schulte K.M., Ostermann P., Roher H.D., Ekkernkamp A., and Laun R.A. (2003). Heat shock protein 70 genotypes HSPA1B and HSPA1L influence cytokine concentrations and interfere with outcome after major injury. Crit. Care Med. 31:73-79.
83. Scoggin C.H., Hyers T.M., Reeves J.T., and Grover R.F. (1977). High-altitude pulmonary edema in the children and young adults of Leadville, Colorado. N. Engl. J. Med. 297:1269-1272.
84. Su B., Xiao C., Deka R., Seielstad M.T., Kangwanpong D., Xiao J., Lu D., Underhill P., Cavalli-Sforza L., Chakraborty R., and Jin L. (2000). Y chromosome haplotypes reveal prehistorical migrations to the Himalayas. Hum. Genetics 107(6):582-590.
85. Thomas S., Bruce C., Birkhead A., and Wang L. (2002). Effect of ecNOS polymorphisms and coronary artery disease upon exhaled nitric oxide. J. Mol. Med. 80:181-186.
86. Tsianos G., Eleftheriou K.I., Hawe E., Woolrich L., Watt M., Watt I., Peacock A., Montgomery H., and Grant S. (2005). Performance at altitude and angiotensin I-converting enzyme genotype. Eur. J. Appl. Physiol. 93:630-633.
87. Van Geel P.P., Pinto Y.M., Voors A.A., Buikema H., Oosterga M., Crijns H.J., and van Gilst W.H. (2000). Angiotensin II type 1 receptor A1166C gene polymorphism is associated with an increased response to angiotensin II in human arteries. Hypertension. 35:717-721.
88. Vock P., Fretz C., Franciolli M., and Bartsch P. (1989). High-altitude pulmonary edema: findings at high-altitude chest radiography and physical examination. Radiology. 170:661-666.
89. Wang W., Zhang X., and Ma Y. (1998). [Low-concentration nitrous oxide inhalation in the treatment of high-altitude pulmonary edema]. Zhonghua Jie He He Hu Xi Za Zhi 21:212-214 [Zh].
90. Ward M.P., Milledge J.S., and West J.B. (2000). High Altitude Medicine and Physiology, 3rd ed. Arnold, London.
91. Weiss J., Haefeli W.E., Gasse C., Hoffmann M.M., Weyman J., Gibbs S., Mansmann U., and Bartsch P. (2003). Lack of evidence for association of high altitude pulmonary edema and polymorphisms of the NO pathway. High Alt. Med. Biol. 4:355-366.
92. Wen H.C., Lee C.C., Lee W.C., Huang K.S., and Lin M.T. (2002). Chronic hypoxia preconditioning increases survival in rats suffering from heatstroke. Clin. Exp. Pharmacol. Physiol. 29:435-440.
93. West J.B. (2004). The physiologic basis of high-altitude diseases. Ann. Intern. Med. 141:789-800.
94. Woods D.R., Humphries S.E., and Montgomery H.E. (2000). The ACE I/D polymorphism and human physical performance. Trends Endocrinol. Metab. 11:416-420.
95. Wu T., Wang X., Wei C., Cheng H., Wang X., Li Y., Ge D., Zhao H., Young P., Li G., and Wang Z. (2005). Hemoglobin levels in Qinghai-Tibet: different effects of gender for Tibetans vs. Han. J. Appl. Physiol. 98(2): 5898-604.
96. Wu T.Y. (2005). Chronic mountain sickness on the Qinghai-Tibetan plateau. Chin Med. J. (English) 118: 161-168.
97. Xu J., Wiesch D.G., and Meyers D.A. (1998). Genetics of complex human diseases: genome screening, association studies and fine mapping. Clin. Exp. Allergy 28:1-5.
98. Yaron M., Niermeyer S., Lindgren K.N., and Honigman B. (2002). Evaluation of diagnostic criteria and incidence of acute mountain sickness in preverbal children. Wilderness Environ. Med. 13:21-26.
99. Zhu X., Bouzekri N., Southam L., Cooper R.S., Adeyemo A., McKenzie C.A., Luke A., Chen G., Elston R.C., and
100. Ward R. (2001). Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am. J. Hum. Genetics 68:1139-1148.